Back to URGN

Kynam Capital Management, LP → URGN

Kynam Capital Management, LP URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
3
Latest value
$98.9M
Q3 2026
Peak value
$98.9M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$40.4M
Q2 2026$89.6M
Q3 2026$98.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$98.9M2.43M——
Q2 2026$89.6M2.43M——
Q1 2026$40.4M2.25M——

Other funds holding URGN

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M